STRS Ohio’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,900
Closed -$602K 2168
2025
Q4
$602K Buy
22,900
+22,600
+7,533% +$586K ﹤0.01% 927
2025
Q3
$6.78K Hold
300
﹤0.01% 2169
2025
Q2
$5.96K Hold
300
﹤0.01% 2178
2025
Q1
$5.07K Hold
300
﹤0.01% 1896
2024
Q4
$5.54K Hold
300
﹤0.01% 1861
2024
Q3
$6.52K Sell
300
-6,800
-96% -$152K ﹤0.01% 1944
2024
Q2
$139K Buy
7,100
+700
+11% +$14.6K ﹤0.01% 1642
2024
Q1
$138K Sell
6,400
-400
-6% -$9.93K ﹤0.01% 1636
2023
Q4
$196K Sell
6,800
-2,100
-24% -$56.2K ﹤0.01% 1564
2023
Q3
$237K Hold
8,900
﹤0.01% 1522
2023
Q2
$329K Sell
8,900
-9,000
-50% -$314K ﹤0.01% 1451
2023
Q1
$558K Hold
17,900
﹤0.01% 1244
2022
Q4
$533K Hold
17,900
﹤0.01% 1296
2022
Q3
$682K Buy
17,900
+2,400
+15% +$120K ﹤0.01% 1131
2022
Q2
$845K Sell
15,500
-400
-3% -$22K ﹤0.01% 1019
2022
Q1
$992K Buy
15,900
+13,600
+591% +$895K ﹤0.01% 1045
2021
Q4
$231K Buy
2,300
+900
+64% +$79.1K ﹤0.01% 1695
2021
Q3
$125K Buy
1,400
+1,200
+600% +$109K ﹤0.01% 1899
2021
Q2
$18K Buy
+200
New +$16K ﹤0.01% 2183
2021
Q1
Sell
-1,000
Closed -$52K 2208
2020
Q4
$52K Sell
1,000
-3,900
-80% -$163K ﹤0.01% 1988
2020
Q3
$196K Buy
4,900
+4,200
+600% +$131K ﹤0.01% 1681
2020
Q2
$11K Buy
+700
New +$10.7K ﹤0.01% 2088
2017
Q2
Sell
-1,200
Closed -$13K 1959
2017
Q1
$13K Hold
1,200
﹤0.01% 1843
2016
Q4
$13K Buy
+1,200
New +$11.3K ﹤0.01% 1873

Other funds holding FLGT

STRS Ohio's FLGT Position: Q1 2026 in Review

STRS Ohio sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 22,900 shares — an estimated $602K sold.

STRS Ohio first reported a position in FLGT in Q4 2016 and held it in 24 quarters. The position peaked at $992K in Q1 2022. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • STRS Ohio reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • STRS Ohio sold 22,900 Fulgent Genetics shares in Q1 2026, an estimated $602K.
  • STRS Ohio first reported a position in Fulgent Genetics in Q4 2016 and held it in 24 quarters.
  • STRS Ohio's Fulgent Genetics position peaked at $992K in Q1 2022.
  • 158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.